| Mendeleev Communications |
|
|
|
|
|
Эта публикация цитируется в 2 научных статьях (всего в 2 статьях) Communications Integration of anticancer drug ruboxyl into the membrane of fullerene-based vesicle enhances its therapeutic performance O. A. Kraevayaa, E. A. Khakinab, N. A. Emelianova, A. F. Shestakovac, T. E. Sashenkovaa, D. V. Mishchenkoacd, P. A. Troshinae a Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russian Federation b A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Moscow, Russian Federation c Department of Fundamental Physical and Chemical Engineering, M.V. Lomonosov Moscow State University, Moscow, Russian Federation d Moscow Region State Pedagogical University, Mytishi, Moscow Region, Russian Federation e Zhengzhou Research Institute, Harbin Institute of Technology, Zhengzhou, China 
Образец цитирования: O. A. Kraevaya, E. A. Khakina, N. A. Emelianov, A. F. Shestakov, T. E. Sashenkova, D. V. Mishchenko, P. A. Troshin, “Integration of anticancer drug ruboxyl into the membrane of fullerene-based vesicle enhances its therapeutic performance”, Mendeleev Commun., 34:2 (2024),
Эта публикация цитируется в следующих 2 статьяx:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Обратная связь:math-net2025_03@mi-ras.ru |
Пользовательское соглашение
|
Регистрация посетителей портала |
Логотипы |
|